Randomized double-blind clinical trial of a new human epoetin versus a commercially available formula for anemia control in patients on hemodialysis

Randomized double-blind clinical trial of a new human epoetin versus a commercially available formula for anemia control in patients on hemodialysis

OBJECTIVES: Anemia is a common complication among chronic kidney disease patients on hemodialysis, occurring mostly due to erythropoietin deficiency. This randomized noninferiority trial sought to compare the efficacy and safety of a new epoetin formulation developed by Bio-Manguinhos, a biologics m...

Full description

Bibliographic Details
Main Authors: Paulo D. Picon, Suzane Cristina M. Pribbernow, Carlos A. Prompt, Suzana C. Schacher, Veronica V.H. Antunes, Bianca P. Mentz, Fabiane L. Oliveira, Celia Mariana B. de Souza, Fernando C. Schacher
Format: Article
Language:English
Published: Elsevier España 2014-08-01
Series:Clinics
Subjects:
Epoetin Alfa
Randomized Controlled Trial
Chronic Kidney Disease
Anemia
Hemodialysis
Erythropoietin
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322014000800547&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322014000800547&lng=en&tlng=en

Similar Items